OrbiMed’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $33.6M | Buy |
114,700
+15,600
| +16% | +$5.13M | 0.67% | 45 |
|
|
2025
Q4 | $34.7M | Buy |
+99,100
| New | +$33.5M | 0.71% | 44 |
|
|
2024
Q4 | – | Sell |
-106,200
| Closed | -$55.2M | – | 124 |
|
|
2024
Q3 | $55.2M | Sell |
106,200
-61,900
| -37% | -$33.1M | 1% | 29 |
|
|
2024
Q2 | $91.1M | Hold |
168,100
| – | – | 1.8% | 14 |
|
|
2024
Q1 | $87.2M | Buy |
168,100
+26,600
| +19% | +$13.2M | 1.6% | 18 |
|
|
2023
Q4 | $66.7M | Buy |
+141,500
| New | +$65.4M | 1.33% | 28 |
|
|
2021
Q4 | – | Sell |
-207,100
| Closed | -$77.2M | – | 161 |
|
|
2021
Q3 | $77.2M | Sell |
207,100
-128,600
| -38% | -$48.9M | 0.85% | 36 |
|
|
2021
Q2 | $128M | Buy |
335,700
+49,100
| +17% | +$18.8M | 1.3% | 23 |
|
|
2021
Q1 | $103M | Sell |
286,600
-23,900
| -8% | -$7.69M | 0.96% | 32 |
|
|
2020
Q4 | $99.7M | Buy |
+310,500
| New | +$95.3M | 0.87% | 32 |
|
|
2020
Q1 | – | Sell |
-106,600
| Closed | -$32.2M | – | 149 |
|
|
2019
Q4 | $32.2M | Sell |
106,600
-148,000
| -58% | -$40.7M | 0.46% | 55 |
|
|
2019
Q3 | $61.1M | Sell |
254,600
-107,000
| -30% | -$29.3M | 1.16% | 31 |
|
|
2019
Q2 | $102M | Buy |
361,600
+36,400
| +11% | +$9.94M | 1.58% | 17 |
|
|
2019
Q1 | $93.3M | Buy |
325,200
+19,800
| +6% | +$5.73M | 1.44% | 18 |
|
|
2018
Q4 | $80.2M | Sell |
305,400
-168,600
| -36% | -$46.4M | 1.48% | 19 |
|
|
2018
Q3 | $130M | Sell |
474,000
-57,800
| -11% | -$15M | 1.56% | 19 |
|
|
2018
Q2 | $127M | Buy |
+531,800
| New | +$123M | 1.51% | 19 |
|
|
2018
Q1 | – | Sell |
-658,718
| Closed | -$148M | – | 143 |
|
|
2017
Q4 | $148M | Sell |
658,718
-268,900
| -29% | -$57.3M | 1.87% | 15 |
|
|
2017
Q3 | $176M | Buy |
927,618
+7,000
| +0.8% | +$1.33M | 1.68% | 16 |
|
|
2017
Q2 | $173M | Buy |
920,618
+58,018
| +7% | +$10.4M | 1.82% | 18 |
|
|
2017
Q1 | $143M | Sell |
862,600
-159,000
| -16% | -$25.3M | 1.62% | 19 |
|
|
2016
Q4 | $147M | Buy |
+1,021,600
| New | +$137M | 1.87% | 18 |
|
|
2015
Q1 | – | Sell |
-138,800
| Closed | -$17.4M | – | 137 |
|
|
2014
Q4 | $17.4M | Buy |
138,800
+20,300
| +17% | +$2.51M | 0.17% | 80 |
|
|
2014
Q3 | $14.2M | Buy |
118,500
+58,500
| +98% | +$6.71M | 0.15% | 87 |
|
|
2014
Q2 | $6.46M | Buy |
+60,000
| New | +$6.18M | 0.08% | 101 |
|
|
2014
Q1 | – | Sell |
-429,000
| Closed | -$39.6M | – | 143 |
|
|
2013
Q4 | $39.6M | Sell |
429,000
-777,000
| -64% | -$69M | 0.58% | 45 |
|
|
2013
Q3 | $101M | Buy |
1,206,000
+19,000
| +2% | +$1.63M | 1.8% | 20 |
|
|
2013
Q2 | $97.1M | Buy |
+1,187,000
| New | +$88.8M | 2.06% | 15 |
|
Other funds holding ELV
VCM
VPM
OrbiMed's ELV Position: Q1 2026 in Review
OrbiMed increased its Elevance Health (ELV) stake by 16% in Q1 2026, buying an estimated $5.13M and bringing the position to 114,700 shares worth $33.6M. The position accounts for 0.67% of the portfolio, ranked #45.
OrbiMed first reported a position in ELV in Q2 2013 and has held it in 28 quarters since. The position peaked at $176M in Q3 2017. 1,463 funds tracked by Wall St. Rank hold ELV as of Q1 2026.
- OrbiMed held 114,700 shares of Elevance Health worth $33.6M as of Q1 2026.
- OrbiMed bought 15,600 Elevance Health shares in Q1 2026, an estimated $5.13M.
- Elevance Health made up 0.67% of OrbiMed's portfolio in Q1 2026, its #45 holding.
- OrbiMed first reported a position in Elevance Health in Q2 2013 and has held it in 28 quarters since.
- OrbiMed's Elevance Health position peaked at $176M in Q3 2017.
- 1,463 funds tracked by Wall St. Rank held Elevance Health as of Q1 2026.
Based on OrbiMed's 13F filing for Q1 2026, filed 15 May 2026.